ABSTRACT
Background Diabetes mellitus (DM), one of the most common metabolic diseases in the world, is a chronic metabolic disorder characterized by persistent hyperglycemia. In diabetic patients, ocular symptoms can develop. One commonly found ocular disease is dry eye disease (DED). DED is a multifactorial disease characterized by instability of the tear layer that causes various symptoms and/or visual impairment, usually accompanied by damage to the ocular surface.
Objective This study aims to determine the prevalence of dry eye disease (DED) in type 2 DM patients and to assess the correlation between DED and various type 2 DM-related conditions in Indonesia.
Methodology This study is a cross-sectional observational study. The study population includes all consecutive patients diagnosed with type 2 DM between Feb 5 and Mar 26, 2024, at three hospitals and two clinics in Jakarta. The DED assessment was conducted using the DEQ-5 questionnaire, translated and validated in Bahasa, Indonesia. The Kolmogorov-Smirnov normality test and Spearman correlation test were performed on all data sets to determine the correlation between DEQ-5 outcome and the patient’s age, disease duration, fasting blood glucose (FBG) levels, and HbA1c levels.
Result A total of 309 patients were recruited in this study. The patients’ age varies from 23 to 84 years old, and the majority of them have had type 2 DM for five years or less. From 309 patients, 264 FBG and 72 HbA1c test results were recorded. Through the DEQ-5 questionnaire, 64 (20.71%) scored higher than 6, indicating they are experiencing DED. Among the factors considered, including age, gender, duration of disease, FBG level, and HbA1c level, only the FBG level correlated with DED (rs = .186, n = 263, p < .002).
Conclusion There’s a positive correlation between the FBG level and DED. Elevating FBG levels are associated with an increased likelihood of developing DED.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by Fatmawati General hospital, DKI Jakarta, Indonesia.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of Fatmawati General Hospital gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript.
